On the stock market since 1983, it operates in the world of health and science. It has 37 employees. Now — the numbers.
This is an established company with proven profits.
The gap is $112K. In times of high interest rates, a gap like that can squeeze a company.
Buys outnumber sells, but taken together the trades don’t add up to a strong signal of confidence.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit power and business quality lead the class.
A solid grade overall — yet the debt outweighs the cash. The strength here comes from earnings power.
The price looks reasonable next to what the company earns.
This grade is a blend: the profit side is strong, the sales tempo slow.
The price is looking for direction — no strong breakout, no collapse.
No real weak spot in any of the five subjects — a balanced report card.
angles, checked one by one.
The 4 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Profit per Sale: The profit kept from each sale is thin.
The stock trades 26% below its peak. The market has trimmed its expectations for the company.
The net profit margin is 1,821% — still a thick cushion, though costs have been eating into it lately.
The average analyst price target is $23.00 — 111% above today’s price.
It pays out $0.06 per share each year — regular cash for whoever holds the stock.
Since the drop from its peak, buyer appetite hasn’t come back. Council score: 0/10.
As the slice kept from each sale thins out, so does the profit. Council score: 3/10.
No clear buy-side message is coming from the executive floor. Council score: 3/10.
On our five-subject report card, DXR sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: DXR is an established business that has proven its profits for years. The real debate here isn’t the price — it’s whether the company can keep up this pace.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.